Cargando…
The prognostic value of 4.1 mRNA expression in non-small cell lung cancer
BACKGROUND: The mechanism of 4.1 family in human cancer has not been elucidated. In this study we investigate the value as a prognostic factor of mRNA expression of 4.1 family in non-small cell lung cancer (NSCLC). METHODS: A survival analysis was carried out through the Kaplan-Meier plotter (KM plo...
Autores principales: | Xiang, Yuying, Shan, Feiyu, Feng, Guan, Guo, Kaibo, Ruan, Shanming, Huang, Dawei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798428/ https://www.ncbi.nlm.nih.gov/pubmed/35116449 http://dx.doi.org/10.21037/tcr-20-2501 |
Ejemplares similares
-
Expression of Protein 4.1 Family in Breast Cancer: Database Mining for 4.1 Family Members in Malignancies
por: Feng, Guan, et al.
Publicado: (2019) -
Nomograms for Predicting Specific Distant Metastatic Sites and Overall Survival of Breast Invasive Ductal Carcinoma Patients After Surgery: A Large Population-Based Study
por: Feng, Yuqian, et al.
Publicado: (2022) -
Association between the overexpression of Her3 and clinical pathology and prognosis of colorectal cancer: A meta-analysis
por: Yan, Qingying, et al.
Publicado: (2018) -
Inhibition to Epithelial-Mesenchymal Transition and Metastatic
Potential In Colorectal Cancer Cell By Combination of Traditional Chinese
Medicine Formulation Jiedu Sangen Decoction and PD-L1 Inhibitor
por: Shan, Feiyu, et al.
Publicado: (2020) -
The Role of Combination Maintenance with Pemetrexed and Bevacizumab for Advanced Stage Nonsquamous Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
por: Shan, Feiyu, et al.
Publicado: (2018)